Yuhan Corporation - Product Pipeline Review - 2016

  • ID: 3759023
  • Company Profile
  • 54 pages
  • Global Markets Direct
1 of 4
Yuhan Corporation - Product Pipeline Review - 2016

Summary

‘Yuhan Corporation - Product Pipeline Review - 2016’, provides an overview of the Yuhan Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Yuhan Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Yuhan Corporation
- The report provides overview of Yuhan Corporation including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Yuhan Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Yuhan Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Yuhan Corporation’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Yuhan Corporation
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Yuhan Corporation’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Yuhan Corporation Snapshot

Yuhan Corporation Overview

Key Information

Key Facts

Yuhan Corporation - Research and Development Overview

Key Therapeutic Areas

Yuhan Corporation - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Yuhan Corporation - Pipeline Products Glance

Yuhan Corporation - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

Yuhan Corporation - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Yuhan Corporation - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Yuhan Corporation - Drug Profiles

(metformin hydrochloride SR + rosuvastatin calcium)

Product Description

Mechanism of Action

R&D Progress

bilastine

Product Description

Mechanism of Action

R&D Progress

YH-12852

Product Description

Mechanism of Action

R&D Progress

YH-14618

Product Description

Mechanism of Action

R&D Progress

(amlodipine maleate + chlorthalidone + telmisartan)

Product Description

Mechanism of Action

R&D Progress

YH-22189

Product Description

Mechanism of Action

R&D Progress

YH-1177

Product Description

Mechanism of Action

R&D Progress

YH-14619

Product Description

Mechanism of Action

R&D Progress

YH-18406

Product Description

Mechanism of Action

R&D Progress

YH-18420

Product Description

Mechanism of Action

R&D Progress

YH-24931

Product Description

Mechanism of Action

R&D Progress

YH-25348

Product Description

Mechanism of Action

R&D Progress

YH-25448

Product Description

Mechanism of Action

R&D Progress

YH-25723

Product Description

Mechanism of Action

R&D Progress

YH-BIO

Product Description

Mechanism of Action

R&D Progress

YH-GKA

Product Description

Mechanism of Action

R&D Progress

YH-NCE2

Product Description

Mechanism of Action

R&D Progress

YH-NCE3

Product Description

Mechanism of Action

R&D Progress

YH-NCE4

Product Description

Mechanism of Action

R&D Progress

YH-siRNA1

Product Description

Mechanism of Action

R&D Progress

YH-siRNA2

Product Description

Mechanism of Action

R&D Progress

YH-siRNA3

Product Description

Mechanism of Action

R&D Progress

Yuhan Corporation - Pipeline Analysis

Yuhan Corporation - Pipeline Products by Target

Yuhan Corporation - Pipeline Products by Route of Administration

Yuhan Corporation - Pipeline Products by Molecule Type

Yuhan Corporation - Pipeline Products by Mechanism of Action

Yuhan Corporation - Recent Pipeline Updates

Yuhan Corporation - Dormant Projects

Yuhan Corporation - Company Statement

Yuhan Corporation - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Yuhan Corporation - Key Manufacturing Facilities

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Yuhan Corporation, Key Information

Yuhan Corporation, Key Facts

Yuhan Corporation - Pipeline by Indication, 2016

Yuhan Corporation - Pipeline by Stage of Development, 2016

Yuhan Corporation - Monotherapy Products in Pipeline, 2016

Yuhan Corporation - Combination Treatment Modalities in Pipeline, 2016

Yuhan Corporation - Partnered Products in Pipeline, 2016

Yuhan Corporation - Partnered Products/ Combination Treatment Modalities, 2016

Yuhan Corporation - Phase III, 2016

Yuhan Corporation - Phase II, 2016

Yuhan Corporation - Phase I, 2016

Yuhan Corporation - Preclinical, 2016

Yuhan Corporation - Pipeline by Target, 2016

Yuhan Corporation - Pipeline by Route of Administration, 2016

Yuhan Corporation - Pipeline by Molecule Type, 2016

Yuhan Corporation - Pipeline Products by Mechanism of Action, 2016

Yuhan Corporation - Recent Pipeline Updates, 2016

Yuhan Corporation - Dormant Developmental Projects,2016

Yuhan Corporation, Other Locations

Yuhan Corporation, Subsidiaries

Yuhan Corporation, Key Manufacturing Facilities

List of Figures

Yuhan Corporation - Pipeline by Top 10 Indication, 2016

Yuhan Corporation - Pipeline by Stage of Development, 2016

Yuhan Corporation - Monotherapy Products in Pipeline, 2016

Yuhan Corporation - Combination Treatment Modalities in Pipeline, 2016

Yuhan Corporation - Partnered Products in Pipeline, 2016

Yuhan Corporation - Pipeline by Top 10 Target, 2016

Yuhan Corporation - Pipeline by Route of Administration, 2016

Yuhan Corporation - Pipeline by Molecule Type, 2016

Yuhan Corporation - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll